文献速递泌尿系结石前列腺增生与排尿功能障碍男科与性医学

泌尿外科非癌症手术中血栓与出血的手术特异性风险:系统综述与Meta分析

Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol · 2017-03-09

该系统综述与Meta分析纳入37项当代观察性研究,评估11种泌尿外科非癌症手术后4周内有症状静脉血栓栓塞症(VTE)与需再次手术的出血风险。开放受者肾切除术(肾移植)的VTE与出血风险最高,分别达1.8-7.4%和2.4%;8/11种手术VTE风险低,6/7种手术出血风险低;证据质量低或极低。作者认为部分手术(如高危患者的肾移植手术)延长预防措施是合理的,而另一些手术(如低危患者的前列腺经尿道切除术和女性盆腔重建手术)则不然。

要点

  • 开放受者肾切除术(肾移植)的VTE风险为1.8-7.4%(取决于患者特征),出血风险为2.4%。
  • 8/11种手术的VTE风险低(低/中危患者0.2-0.7%,高危患者0.8-1.4%)。
  • 6/7种手术的出血风险低(≤0.5%),4种手术无出血估计值。

核心结论

  • 尽管因证据质量低而限制推断,结果提示部分手术(如高危患者的肾移植手术)延长预防措施是合理的,而另一些手术(如低危患者的前列腺经尿道切除术和女性盆腔重建手术)则不然。

研究设计与样本

  • 系统综述与Meta分析,检索当代观察性研究,估计泌尿外科手术后4周内有症状VTE或需再次手术的出血风险,采用GRADE方法评估证据质量。
  • 共纳入37项符合条件的研究,报告了11种泌尿外科非癌症手术。

主要发现

  • 开放受者肾切除术(肾移植)研究报告的VTE和出血风险最高,VTE风险为1.8-7.4%(取决于患者特征),出血风险为2.4%。
  • 8/11种手术的VTE风险低(低/中危患者0.2-0.7%,高危患者0.8-1.4%),6/7种手术的出血风险低(≤0.5%),4种手术无出血估计值。
  • 预防持续时间在手术内和手术间差异很大,例如开放受者肾切除术(肾移植)研究的中位数为12.3天(四分位距[IQR] 3.1-55),经皮肾镜取石术、开放脱垂手术和盆腔重建手术研究的中位数为1天(IQR 0-1.3)。
  • 支持这些估计值的证据质量低或极低。

关键数值与推荐

  • 开放受者肾切除术(肾移植):VTE风险1.8-7.4%(取决于患者特征),出血风险2.4%。
  • 8/11种手术VTE风险低:低/中危患者0.2-0.7%,高危患者0.8-1.4%。
  • 6/7种手术出血风险低:≤0.5%;4种手术无出血估计值。
  • 预防持续时间中位数:开放受者肾切除术(肾移植)研究12.3天(IQR 3.1-55);经皮肾镜取石术、开放脱垂手术和盆腔重建手术研究1天(IQR 0-1.3)。

临床怎么用

  • 作者认为,延长预防措施对某些手术(如高危患者的肾移植手术)是合理的,但对其他手术(如低危患者的前列腺经尿道切除术和女性盆腔重建手术)则不然。

局限性

  • 支持这些估计值的证据质量低或极低。
  • 由于证据质量低,推断受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Pharmacological thromboprophylaxis involves a trade-off between a reduction in venous thromboembolism (VTE) and increased bleeding. No guidance specific for procedure and patient factors exists in urology. OBJECTIVE: To inform estimates of absolute risk of symptomatic VTE and bleeding requiring reoperation in urological non-cancer surgery. EVIDENCE ACQUISITION: We searched for contemporary observational studies and estimated the risk of symptomatic VTE or bleeding requiring reoperation in the 4 wk after urological surgery. We used the GRADE approach to assess the quality of the evidence. EVIDENCE SYNTHESIS: The 37 eligible studies reported on 11 urological non-cancer procedures. The duration of prophylaxis varied widely both within and between procedures; for example, the median was 12.3 d (interquartile range [IQR] 3.1-55) for open recipient nephrectomy (kidney transplantation) studies and 1 d (IQR 0-1.3) for percutaneous nephrolithotomy, open prolapse surgery, and reconstructive pelvic surgery studies. Studies of open recipient nephrectomy reported the highest risks of VTE and bleeding (1.8-7.4% depending on patient characteristics and 2.4% for bleeding). The risk of VTE was low for 8/11 procedures (0.2-0.7% for patients with low/medium risk; 0.8-1.4% for high risk) and the risk of bleeding was low for 6/7 procedures (≤0.5%; no bleeding estimates for 4 procedures). The quality of the evidence supporting these estimates was low or very low. CONCLUSIONS: Although inferences are limited owing to low-quality evidence, our results suggest that extended prophylaxis is warranted for some procedures (eg, kidney transplantation procedures in high-risk patients) but not others (transurethral resection of the prostate and reconstructive female pelvic surgery in low-risk patients). PATIENT SUMMARY: The best evidence suggests that the benefits of blood-thinning drugs to prevent clots after surgery outweigh the risks of bleeding in some procedures (such as kidney transplantation procedures in patients at high risk of clots) but not others (such as prostate surgery in patients at low risk of clots).

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Tikkinen KAO, Craigie S, Agarwal A, et al. Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis. Eur Urol. 2017. PMID: 28284738. doi:10.1016/j.eururo.2017.02.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。